Form 4: Clorox Director Christopher J. Williams Reports Acquisition and Disposal of Common Stock

Director Christopher J. Williams reports acquiring and disposing of Clorox common stock, along with acquiring deferred stock units through dividend reinvestment.

Summary

• On March 28, 2024, Christopher J. Williams, a director of Clorox, acquired 212 shares of common stock at a price of $153.11 per share.
• On the same day, Williams disposed of 212 shares of common stock.
• On February 9, 2024, Williams acquired 131.0193 deferred stock units through dividend reinvestment.
• These deferred stock units will be settled in Clorox stock upon the director's retirement or termination of service.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions, so the sentiment is neutral.

Future Outlook

The deferred stock units will be settled 100% in Clorox stock upon the director's retirement or termination of service.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common practice for publicly traded companies. It provides transparency into the trading activities of key personnel.

Comparison to Industry Standards

• Director stock transactions are a common occurrence in publicly traded companies like Clorox.
• Similar filings are made by directors and officers of companies such as Procter & Gamble (PG), Unilever (UL), and Colgate-Palmolive (CL), reflecting their individual investment decisions and compensation structures.
• The reporting requirements are standardized by the SEC to ensure transparency and prevent insider trading.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the stock transactions of a company director.
• It assures stakeholders that insider trading is being monitored and reported.

Key Dates